These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 26411419
1. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway. Shu XR, Wu J, Sun H, Chi LQ, Wang JH. Diagn Pathol; 2015 Sep 28; 10():177. PubMed ID: 26411419 [Abstract] [Full Text] [Related]
2. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Fu X, Feng J, Zeng D, Ding Y, Yu C, Yang B. Biosci Rep; 2014 Apr 01; 34(2):. PubMed ID: 27919028 [Abstract] [Full Text] [Related]
3. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells. Arjumand W, Merry CD, Wang C, Saba E, McIntyre JB, Fang S, Kornaga E, Ghatage P, Doll CM, Lees-Miller SP. Oncotarget; 2016 Dec 13; 7(50):82424-82439. PubMed ID: 27489350 [Abstract] [Full Text] [Related]
4. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling. He LF, Xu HW, Chen M, Xian ZR, Wen XF, Chen MN, Du CW, Huang WH, Wu JD, Zhang GJ. Oncotarget; 2017 Mar 14; 8(11):17573-17585. PubMed ID: 28407679 [Abstract] [Full Text] [Related]
5. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H, Yang Y, Xiao J, Yang S, Liu Y, Kang W, Li X, Zhang F. Microvasc Res; 2014 May 14; 93():1-8. PubMed ID: 24603190 [Abstract] [Full Text] [Related]
8. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression. Su J, Zhang F, Li X, Liu Z. Biochem Biophys Res Commun; 2019 Jun 25; 514(2):510-517. PubMed ID: 31056260 [Abstract] [Full Text] [Related]
9. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling. Jiang L, Shi S, Li F, Shi Q, Zhong T, Zhang H, Xia Y. Mol Med Rep; 2021 May 25; 23(5):. PubMed ID: 33760204 [Abstract] [Full Text] [Related]
10. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation. Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC. Oncotarget; 2016 May 31; 7(22):31892-906. PubMed ID: 26895469 [Abstract] [Full Text] [Related]
11. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen J, Fu JH, Yang H. Cancer Lett; 2016 Jul 10; 377(1):97-104. PubMed ID: 27130665 [Abstract] [Full Text] [Related]
18. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation. Bai C, Yang X, Zou K, He H, Wang J, Qin H, Yu X, Liu C, Zheng J, Cheng F, Chen J. Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 10; 389(6):573-84. PubMed ID: 26935715 [Abstract] [Full Text] [Related]
19. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma. Zhang W, He W, Shi Y, Gu H, Li M, Liu Z, Feng Y, Zheng N, Xie C, Zhang Y. PLoS One; 2016 Jun 10; 11(12):e0167449. PubMed ID: 27941992 [Abstract] [Full Text] [Related]
20. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties. Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y, Wu D. J Cell Biochem; 2014 Jun 10; 115(6):1112-21. PubMed ID: 24356998 [Abstract] [Full Text] [Related] Page: [Next] [New Search]